¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other transitory neonatal disorders of thyroid function, NEC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
  • neonatal thrombocytopenia
    ½Å»ý¾ÆÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • articulatory function
    ¹ß¼º±â´É, ±¸À½±â´É
  • autonomous function
    ÀÚÀ²±â´É
  • compensatory function
    º¸»ó±â´É
  • conceptual function
    °³³ä±â´É
  • cardiac function curve
    ½ÉÀå±â´É°î¼±
  • cumulative distribution function
    ´©ÀûºÐÆ÷ÇÔ¼ö
  • discriminative sensory function
    ½Äº°°¨°¢±â´É
  • executant ego function
    ÁýÇàÀھƱâ´É
  • feeling function
    °¨Á¤±â´É
  • function
    1. ±â´É 2. ÀÛ¿ë 3. ÇÔ¼ö
  • function distribution
    ÇÔ¼öºÐÆ÷
  • holding function
    ÁöÁö±â´É
  • homeostatic function
    Ç׻󼺱â´É
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • neonatal death
    ½Å»ý¾Æ»ç¸Á, ¿µ¾Æ»ç
  • neonatal diarrhea
    ½Å»ý¾Æ¼³»ç
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°
  • transient familial neonatal hyperbilirubinemia
    Àϰú¼º°¡Á·½Å»ý¾Æ°íºô¸®·çºóÇ÷Áõ
  • neonatal infection
    °«³­¾Ö°¨¿°, ½Å»ý¾Æ°¨¿°
  • neonatal line
    ù¼ºÀå¼±
  • neonatal hair loss
    ½Å»ý¾ÆÅ»¸ð
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á·ü
  • transient neonatal pustular melanosis
    Àϰú¼º½Å»ý¾Æ°í¸§¹°ÁýÈæ»öÁõ
  • neonatal period
    ½Å»ý¾Æ±â
  • neonatal purpura
    ½Å»ý¾ÆÀÚ»ö¹Ý
  • neonatal thrombocytopenia
    ½Å»ý¾ÆÀúÇ÷¼ÒÆÇÁõ
  • neonatal thymectomy
    ½Å»ý¾Æ°¡½¿»ùÀýÁ¦(¼ú)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gustatory function
    ¹Ì°¢±â´É
  • hearing function
    û°¢±â´É
  • hemoglobin synthesis/function
    Ç÷»ö¼ÒÇÕ¼º/±â´É
  • hemorrhagic diathesis,defective platelet function
    Ç÷¼ÒÆÇ±â´É°á¼Õ(úìá³÷ùѦÒöÌÀáß)
  • holding function
    ÁöÁö ±â´É(ò¨ò¥ ѦÒö)
  • homeostatic function
    Ç×»ó¼º ±â´É(ѦÒö).
  • immunologic function
    ¸é¿ª±â´É.
  • phonatory function
    ¹ß¼º±â´É(¡­Ñ¦Òö).
  • phonatory function
    ¹ß¼º±â´É
  • postictal disturbance of cerebral function
    ¹ßÀÛÈÄ´ë³ú±â´ÉÀå¾Ö(Û¡íÂý­ÓÞÒà ѦÒöî¡äô).
  • power function graph
    Èû±â´É±×·¡ÇÁ
  • primitive function
    ¿ø½Ã±â´É(ÊÙË»ËÀ).
  • probability function
    È®·üÇÔ¼ö(ÊṴ̀Ëà).
  • pulmonary function test
    Æó±â´É°Ë»ç (¡­ËþÞÛ).
  • radial function
    µ¿°æÇÔ¼ö(ÔÑÌÓùÞâ¦).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • genetic disorders
    À¯Àü¼º Àå¾Ö(Áúȯ)(ë¶îîàõ î¡äô)
  • hemostatic disorders
    Ç÷¾×ÀÀ°íÁúȯ
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • isoimmune neonatal neutropenia
    ½Å»ý¾Æµ¿Á¾¸é¿ª¼º È£Áß±¸°¨¼Ò(Áõ).
  • larynx, congenital disorders of the
    ¼±Ãµ(¼º) ÈĵÎÁúȯ
  • learning disorders
    ÇнÀÀå¾Ö(ùÊã§î¡äô)(º´)
  • mendelian disorders
    ¸àµ¨ À¯Àü¼º Áúȯ(¡­ë¶îîàõ òðü´)
  • monoarticular disorders
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • movement disorders
  • myeloproliferative disorders
    °ñ¼öÁõ½Ä¼ºÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PFT pancreatic function test; parafascicular thalamotomy; posterior fossa tumor; prednisone, fluorouraci...
SFI Sexual Function Index; Social Function Index
TFS testicular feminization syndrome; thyroid function study; tube-fed saline
TFT thin-film transistor; thrombus formation time; thyroid function test; tight filum terminale; trifluo...
131I radioactive Iodine(used in Thyroid uptake, Liver & Kidney Scans & Treatment of malignant & nonmalig...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AOD and other drug
OND other neurologic disease
BFNC Benign Familial Neonatal Convulsions
BNBAS Brazelton Neonatal Behavioral Assessment Scale
NAS Neonatal Abstinence Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neonatal period
    ½Å»ý¾Æ±â
  • neonatal purpura fulminans
    Àü°Ý¼º ½Å»ý¾Æ ÀÚ¹Ý
  • neonatal tetany
    ½Å»ý¾Æ Åן´Ï
  • neonatal thyrombocytopenia
    ½Å»ý¾Æ Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • nodular thyroid
    °áÀý¼º °©»ó¼±
    °©»ó¼±ÀÇ Á¾´ë
  • superior thyroid artery
    »ó °©»ó¼± µ¿¸Æ
    ¼³°ñÀÇ ´ë°¢ ¹Ø¿¡¼­ ³ª¿À¸ç ÈÄµÎ¿Í ±â°üÀÇ ¿ÜÃøÀ» µû¶ó Àü¹æÀ¸·Î °¡¼­ °©»ó¼±ÀÇ »óºÎ ¹× Èĵο¡ ºÐÆ÷ÇÑ´Ù.
  • thyroid artery
    °©»ó¼± µ¿¸Æ
  • thyroid carcinoma
    °©»ó¼± ¾Ï
    50´ëÀÇ ¿©¼º¿¡°Ô ÈçÈ÷ ³ªÅ¸³ª´Â °©»ó¼±ÀÇ ¾ÏÁ¾.
  • thyroid crisis
    °©»ó¼± Áßµ¶¹ßÁõ
  • thyroid fever
    °©»ó¼± ¿­
    °¨»ó¼±ÀÇ Áúȯ¿¡ ÀÇÇØ¼­ ¹ß»ýÇÏ´Â ¿­.
  • thyroid gland
    °©»ó»ù, °©»ó¼±
    ÈĵÎÀÇ Àü¸é °©»ó ¿¬°ñ ¾Æ·¡¿¡ ÀÖ´Â ³»ºÐºñ¼±. ³¯°³¸¦ Æí ³ªºñÀÇ ¸ð½À°ú ºñ½ÁÇÑ ÇüÅÂÀε¥, ³ªºñÀÇ ³¯°³¿¡ ÇØ´çµÇ´Â ºÎºÐÀÌ ¿ì¿±°ú Á¿±À̰í, µ¿Ã¼¿¡ ÇØ´çµÇ´Â ºÎºÐÀº ÇùºÎ¶ó°í ÇÑ´Ù. ¿ì¿±°ú Á¿±Àº ÀεÎÀÇ ¹Ù±ù º®¿¡±îÁö Á¢ÂøµÇ¾î ÀÖ´Ù. °¥»öÀÇ ºû±òÀ» ¶ì°í ¹«°Ô´Â 30¡­60 gÀÌ´Ù. Å©±â´Â °³Àο¡ µû¶ó¼­ Â÷À̰¡ ÀÖÁö¸¸, ÀÎü¿¡¼­ °¡Àå Å« ³»ºÐºñ¼±ÀÌ´Ù. °©»ó¼±ÀÇ ³»ºÎ´Â Àß°Ô ¼Ò¿±À¸·Î ³ª´©¾îÁ® Àִµ¥, ±× Ç¥¸é¿¡´Â ¼ö¸¹Àº ÀÛÀº À¶±â°¡ ÀÖ´Ù. ³¹³¹ÀÇ ¼Ò¿±Àº Á¶Á÷ÀûÀ¸·Î´Â Áö¸§ 0.1 mmµµ ¸øµÇ´Â Æó¼â¼ºÀÇ ±¸ÇüÀ¸·Î µÈ ¼ÒÆ÷°¡ ÁýÇÕÇÏ¿© ÀÌ·ç¾îÁ® ÀÖ´Ù. ¼ÒÆ÷ÀÇ º®¿¡´Â ´ÜÃþÀ¸·Î ¹è¿­µÈ ¿ø±âµÕÇü, À°°¢Çü ¶Ç´Â ³³ÀÛÇÑ ¼± ¼¼Æ÷°¡ ÀÖ´Ù. ¼ÒÆ÷ ³»ºÎ¿¡´Â ÄÝ·ÎÀÌµå »óÅÂÀÇ ¹°ÁúÀÌ ÀÖÀ¸³ª ¹Ýµå½Ã ¶È°°Áö´Â ¾Ê´Ù. °©»ó¼±ÀÌ ºÐºñÇϴ ȣ¸£¸óÀº Ƽ·Ï½ÅÀ̸ç, ´Ù·®ÀÇ ¿ä¿Àµå¸¦ ÇÔÀ¯ÇÑ´Ù. ÀÎü¿¡ ÀÖ´Â ¿ä¿ÀµåÀÇ 3/5°¡ °©»ó¼±¿¡ ÇÔÀ¯µÇ¾î ÀÖ´Ù°í ÇÑ´Ù.
  • thyroid membrane
    °©»ó¼± ¸·
  • thyroid scan
    °©»ó¼± ½ºÄµ, °©»ó¼± ÁÖ»ç
    °©»ó¼±ÀÇ Á¾¾ç ¹× °áÀýÀ» º¸±â À§ÇØ I131°ú Tc99m µîÀÇ µ¿À§¿ø¼Ò¸¦ ÀÌ¿ëÇÏ¿© °Ë»çÇÏ´Â ÇÙÀÇÇÐÀû ¹æ¹ý.
  • thyroid suppression test
    °©»ó¼± ¾ï¾Ð ½ÃÇè
  • adrenocortical function
    ºÎ½Å ÇÇÁú ±â´É
    1. ½ºÅ×·ÎÀ̵å È£¸£¸óÀ» ºÐºñ. 2. ±Û·çÄÚÄÝÆ¼ÄÚÀ̵å-´ç°ú Áö¹æ ¹× ´Ü¹éÁú ´ë»ç¿¡ °ü¿©. ¹Ì³×¶ö·Î ÄÝÆ¼ÄÚÀ̵å-ü¾×°ú Na+, K+ÀÇ ´ë»ç¿¡ °ü¿©. ¾Èµå·ÎÁ¨-È¿¼ÒÀÇ °áÇÔÀ¸·Î °ú·® ÃàÀûµÇ¸é ³²¼ºÈ­¸¦ ³ªÅ¸³»´Â ³²¼º È£¸£¸ó ÀÏÁ¾.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
isomeric function The individual function of an isolated segment of the spinal cord.
(05 Mar 2000)
optical transfer function <microscopy> The relationship between the image produced by an optical instrument and the amplitude and phase of a periodic specimen, measured at various spatial frequencies.
The optical transfer function curve, which shows how well contrast is maintained for finer specimen details, is a complex function, of which the real term gives the ratio of amplitudes, and the imaginary term the phase relationships.
When the brightness of the periodic specimen varies as a sine wave, the modulus or absolute value of the optical transfer function becomes the modulation transfer function, when the brightness varies as a square wave, the modulation transfer function is known as a contrast transfer function.
Acronym: OTF
(26 Mar 1998)
ovarian function tests Methods used for assessment of ovarian function.
(12 Dec 1998)
ecosystem function The collective intraspecific and interspecific interactions of the biota, such as primary and secondary production and mutualistic relationships.
The interactions between organisms and the physical environment, such as nutrient cycling, soil development, water budgeting, and flammability.
(09 Oct 1997)
function The special, normal or proper physiologic activity of an organ or part.
Origin: L. Functio, from fungi = to do
(18 Nov 1997)
function corrector A removable orthodontic appliance utilizing oral and facial muscle forces to move teeth and possibly change the relationship of the dental arches.
(05 Mar 2000)
line spread function A measure of the ability of a system to form sharp images; in radiology, determined by measuring the spatial density distribution on film of the X-ray image of a narrow slit in a dense metal, such as uranium; from this can be calculated the modulation transfer function.
(05 Mar 2000)
liver function test <investigation> A test that measures the blood serum level of several enzymes produced by the liver. An elevated liver function test is a sign of possible liver damage.
Examples include: prothrombin time, PTT, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, gamma glutamyl transpeptidase, alkaline phosphatase and serum albumin.
(14 Oct 1997)
lymphocyte function associated antigen A member of the integrin family that is expressed on all leukocytes and binds to ICAM-1 and ICAM-2 on a variety of cells.
(05 Mar 2000)
lymphocyte function-associated antigen-1 A heterodimer molecule widely expressed on cells of haematopoietic origin. Cd11a antigen comprises the alpha chain and the CD18 antigen (antigens, CD18) the beta chain. Lfa-1 is a major receptor of T-cells, B-cells, and granulocytes. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by natural killer cells and granulocytes. Intracellular adhesion molecule-1 (icam-1) has been defined as a ligand for lfa-1.
(12 Dec 1998)
anaemia, neonatal The mildest form of erythroblastosis foetalis in which anaemia is the chief manifestation.
(12 Dec 1998)
benign neonatal convulsions A familial, self-limited epilepsy, beginning at two or three days of age and resolving spontaneously by six months of age; autosomal dominant inheritance.
(05 Mar 2000)
Brazelton's Neonatal Behavioural Assessment Scale A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life.
(05 Mar 2000)
rate, neonatal mortality The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
mortality rate, neonatal The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á